Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 71.82
-0.73 (-1.01%)
At close: Jan 16, 2026
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 42.75 billion as of January 16, 2026. Its market cap has increased by 57.24% in one year.
Market Cap
42.75B
Enterprise Value
39.58B
Revenue
3.85B
Ranking
n/a
PE Ratio
45.63
Stock Price
71.82
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 42.75B, an increase of 16.88%. That is a compound annual growth rate of 2.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 42.75B | 5.51% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 420.16B |
| WuXi AppTec | 308.80B |
| Shenzhen Mindray Bio-Medical Electronics | 246.81B |
| Sichuan Biokin Pharmaceutical | 131.30B |
| Shanghai United Imaging Healthcare | 114.48B |
| Aier Eye Hospital Group | 108.48B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.67B |